IH vs. CHGG, LINC, APEI, VTRU, VSTA, NRDY, QSG, VEDU, YQ, and STG
Should you be buying iHuman stock or one of its competitors? The main competitors of iHuman include Chegg (CHGG), Lincoln Educational Services (LINC), American Public Education (APEI), Vitru (VTRU), Vasta Platform (VSTA), Nerdy (NRDY), QuantaSing Group (QSG), Visionary Education Technology Holdings Group (VEDU), 17 Education & Technology Group (YQ), and Sunlands Technology Group (STG). These companies are all part of the "educational services" industry.
Chegg (NYSE:CHGG) and iHuman (NYSE:IH) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability.
In the previous week, Chegg had 7 more articles in the media than iHuman. MarketBeat recorded 7 mentions for Chegg and 0 mentions for iHuman. iHuman's average media sentiment score of 1.16 beat Chegg's score of 0.00 indicating that Chegg is being referred to more favorably in the media.
Chegg presently has a consensus price target of $7.31, suggesting a potential upside of 97.64%. Given iHuman's higher probable upside, analysts clearly believe Chegg is more favorable than iHuman.
Chegg received 794 more outperform votes than iHuman when rated by MarketBeat users. Likewise, 67.72% of users gave Chegg an outperform vote while only 50.00% of users gave iHuman an outperform vote.
iHuman has higher revenue and earnings than Chegg. Chegg is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.
95.2% of Chegg shares are held by institutional investors. Comparatively, 4.9% of iHuman shares are held by institutional investors. 3.4% of Chegg shares are held by company insiders. Comparatively, 63.6% of iHuman shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
iHuman has a net margin of 17.78% compared to iHuman's net margin of 2.07%. Chegg's return on equity of 20.27% beat iHuman's return on equity.
Chegg has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, iHuman has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.
Summary
Chegg and iHuman tied by winning 8 of the 16 factors compared between the two stocks.
Get iHuman News Delivered to You Automatically
Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
